Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Bennouna

Showing results (31-40 of 59) with videos related to

Pageof 6
Sort By:
Chemotherapy|December 14, 2012
Phase I trial of gemcitabine combined with capecitabine and erlotinib in advanced pancreatic cancer: a clinical and pharmacological studyE Francois, J Bennouna, E Chamorey, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 26, 2013
Phase II study of everolimus-erlotinib in previously treated patients with advanced non-small-cell lung cancerB Besse, N Leighl, J Bennouna, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|May 11, 2006
Negative influence of delayed surgery on survival after preoperative radiotherapy in rectal cancerS Supiot, J Bennouna, E Rio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 16, 2013
Bevacizumab plus chemotherapy continued beyond first progression in patients with metastatic colorectal cancer previously treated with bevacizumab plus chemotherapy: ML18147 study KRAS subgroup findingsS Kubicka, R Greil, T André, et al.
Beneficial Microbes|November 29, 2024
Multifactorial effects of probiotic Parasutterella excrementihominis on gestational inflammation, offspring behaviour and prenatal-stress induced disruptions in tryptophan metabolismJ D Galley, T A Rajasekera, D J Bennouna, et al.
British Journal of Cancer|July 20, 2007
Phase II study of UFT with leucovorin and irinotecan (TEGAFIRI): first-line therapy for metastatic colorectal cancerJ-P Delord, J Bennouna, P Artru, et al.
British Journal of Cancer|January 13, 2006
'A phase II study of oral uracil/ftorafur (UFT) plus leucovorin combined with oxaliplatin (TEGAFOX) as first-line treatment in patients with metastatic colorectal cancer'J Bennouna, H Perrier, B Paillot, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 15, 2015
A phase I/II, open-label, randomised study of nintedanib plus mFOLFOX6 versus bevacizumab plus mFOLFOX6 in first-line metastatic colorectal cancer patientsE Van Cutsem, H Prenen, G D'Haens, et al.
ESMO Open|January 12, 2023
Twelve ESMO Congress 2022 breakthroughs: practicing oncologists' perceptions and potential application on presented dataH K van Halteren, J Bennouna, B Brasiuniene, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 15, 2002
Multicenter non-randomized phase II study of raltitrexed (Tomudex) and oxaliplatin in non-pretreated metastatic colorectal cancer patientsJ-F Seitz, J Bennouna, B Paillot, et al.
Pageof 6

Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
Chemotherapy|December 14, 2012
Phase I trial of gemcitabine combined with capecitabine and erlotinib in advanced pancreatic cancer: a clinical and pharmacological studyE Francois, J Bennouna, E Chamorey, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 26, 2013
Phase II study of everolimus-erlotinib in previously treated patients with advanced non-small-cell lung cancerB Besse, N Leighl, J Bennouna, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|May 11, 2006
Negative influence of delayed surgery on survival after preoperative radiotherapy in rectal cancerS Supiot, J Bennouna, E Rio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 16, 2013
Bevacizumab plus chemotherapy continued beyond first progression in patients with metastatic colorectal cancer previously treated with bevacizumab plus chemotherapy: ML18147 study KRAS subgroup findingsS Kubicka, R Greil, T André, et al.
Beneficial Microbes|November 29, 2024
Multifactorial effects of probiotic Parasutterella excrementihominis on gestational inflammation, offspring behaviour and prenatal-stress induced disruptions in tryptophan metabolismJ D Galley, T A Rajasekera, D J Bennouna, et al.
British Journal of Cancer|July 20, 2007
Phase II study of UFT with leucovorin and irinotecan (TEGAFIRI): first-line therapy for metastatic colorectal cancerJ-P Delord, J Bennouna, P Artru, et al.
British Journal of Cancer|January 13, 2006
'A phase II study of oral uracil/ftorafur (UFT) plus leucovorin combined with oxaliplatin (TEGAFOX) as first-line treatment in patients with metastatic colorectal cancer'J Bennouna, H Perrier, B Paillot, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 15, 2015
A phase I/II, open-label, randomised study of nintedanib plus mFOLFOX6 versus bevacizumab plus mFOLFOX6 in first-line metastatic colorectal cancer patientsE Van Cutsem, H Prenen, G D'Haens, et al.
ESMO Open|January 12, 2023
Twelve ESMO Congress 2022 breakthroughs: practicing oncologists' perceptions and potential application on presented dataH K van Halteren, J Bennouna, B Brasiuniene, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 15, 2002
Multicenter non-randomized phase II study of raltitrexed (Tomudex) and oxaliplatin in non-pretreated metastatic colorectal cancer patientsJ-F Seitz, J Bennouna, B Paillot, et al.
Pageof 6